TeneoBio, Inc. is a biotechnology company that is developing a new class of biologics, Human Heavy Chain Antibodies (UniAbs™), as therapeutics against cancer, autoimmunity, and infectious diseases. TeneoBio has several products in pre-clinical and clinical development for the treatment of multiple myeloma, prostate cancer, and immune disorders.
TeneoBio’s antibody discovery engine...